
Nuvation Bio Inc.
Share · US67080N1191 · NUVB-WT (XNYS)
No Price
n/a
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
- | - | - | - | - | - | - |
Company Profile for Nuvation Bio Inc. Share
Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.
Company Data
Name Nuvation Bio Inc.
Company Nuvation Bio Inc.
Symbol NUVB-WT
Website
http://www.nuvationbio.com
Primary Exchange
NYSE

ISIN US67080N1191
Asset Class Share
Sector Healthcare
Industry Biotechnology
Market Capitalization 816 Mio
Country United States of America
Currency USD
Employees 0,2 T
Address , New York City
Ticker Symbols
Name | Symbol |
---|---|
NYSE | NUVB-WT |
More Shares
Investors who Nuvation Bio Inc. hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.